Cameron’s Law

This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions.

Learn about this bill’s status and read its full summary in the Pocket Congress app.